Shots:
- Alife Health has reported the European CE mark approval of Embryo Predict, an AI-based embryo selection software for in vitro fertilization (IVF)
- Alife will initiate the rollout of Embryo Predict across selected IVF clinics in the EU, building on the company’s progress in the US with the Clinical Decision Support platform & collaborations with leading networks
- Embryo Predict integrates with existing lab infrastructure & uses deep learning to analyze embryo images, generate AI scores, & rank embryos by likelihood of clinical pregnancy, standardizing embryo selection across IVF labs
Ref: PRNewswire| Image: Alife Health | Press Release
Related News:- Vara Reports CE Mark Approval of its Breast Imaging AI for Independent Second Reading of Mammography
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
